Correction to: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing
- Yi Yan 1,2,3,4, ,
- Ke Wu 1,2,3,4, ,
- Jun Chen 5, ,
- Haizhou Liu 1,2,3 ,
- Yi Huang 6 ,
- Yong Zhang 1 ,
- Jin Xiong 1 ,
- Weipeng Quan 7 ,
- Xin Wu 8 ,
- Yu Liang 9 ,
- Kunlun He 10,11 ,
- Zhilong Jia 10,11 ,
- Depeng Wang 8 ,
- Di Liu 1,2,3,4,12,, ,
- Hongping Wei 1,, ,
- Jianjun Chen 1,2,,
- 1. CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety MegaScience, Chinese Academy of Sciences, Wuhan 430071, China
- 2. National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
- 3. Computational Virology Group, Center for Bacteria and Viruses Resources and Bioinformation, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
- 4. University of Chinese Academy of Sciences, Beijing 101409, China
- 5. Wuhan Pulmonary Hospital, Wuhan Tuberculosis Prevention and Treatment Institute, Wuhan 430030, China
- 6. National Biosafety Laboratory, Chinese Academy of Sciences, Wuhan 430071, China
- 7. GrandOmics Biosciences, Wuhan 430000, China
- 8. GrandOmics Biosciences, Beijing 102200, China
- 9. GrandOmics Diagnostics, Wuhan 430000, China
- 10. Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing 100039, China
- 11. Beijing Key Laboratory for Precision Medicine of Chronic Heart Failure, Chinese PLA General Hospital, Beijing 100039, China 12
- 12. First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
Corresponding author: Di Liu, liud@wh.iov.cn
Corresponding author: Hongping Wei, hpwei@wh.iov.cn
Corresponding author: Jianjun Chen, chenjj@wh.iov.cn
- Published Date: 17 November 2021
Abstract: